Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
Research paper

Indian Pediatr 2009;46: 585-590

Clinical Characteristics of Kawasaki Disease According to Age at Diagnosis


Seong Hyun Kim, Ki Hwan Kim and Dong Soo Kim

From Department of Pediatrics, Severance Children’s Hospital, Yonsei University College of Medicine, Seoul, Korea.

Correspondence to: Dr Dong Soo Kim, Severance Children’s Hospital, Yonsei University College of Medicine,
134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, Korea.
Email: [email protected]

Manuscript received: July 21, 2008;
Initial review: September 19, 2008;
Accepted: April 2, 2009.

 

Abstract

Objective: We compared the clinical, laboratory and diagnostic features of Kawasaki disease (KD) in children £6 mo and ³5 y of age to those in the more typical age range at diagnosis (6 mo-5 y of age).

Study design: Retrospective analysis.

Setting: Severeance Children Hospital attached to a Medical School, Korea.

Methods: All children with a discharge diagnosis of KD at Severance Children’s Hospital (2006-2007) were retro-spectively reviewed and grouped according to age at presentation in 3 groups: <6 mo, 6 mo-5 y and ³5 years. Clinical, hematological, and biochemical features and involvement of coronary artery and proportion of Classic vs. Incomplete KD were compared between the 3 groups.

Results: A total of 185 children were identified. Complete KD was found in 63 (34%) children and Incomplete KD in 122 (66%). There was 22(12%) children below 6 months of age, 131 (71%) between 6 months to 5 years) and 32 (17%) above 5 years of age. Clinical, hematological and biochemical features were comparable between the three age groups. Overall, coronary artery lesions occurred in 9% children without any preference for age. The proportion of Classical vs. Incomplete KD was also similar in the three age categories.

Conclusion: The clinical and laboratory phenotype of KD does not vary significantly with age.

Key Words: Age, Clinical features, Kawasaki disease, Korea.


Kawasaki disease (KD) is an acute, self-limited systemic vasculitis of unknown etiology that occurs predominantly in infants and young children and was first described in 1967 by Tomisaku Kawasaki(1-3). Though its incidence varies among countries, higher rates of KD have been reported in Asian countries such as Japan and Korea(5-7). According to a recent nationwide epidemiologic study, the number of Korean children with KD has steadily increased each year with an annual incidence of 105/100,000 children, which is second only to Japan(8).

KD is the leading cause of acquired heart disease in childhood, causing overt damage in up to 15-25% of untreated children and 2-4% of those who receive appropriate treatment, and may lead to myocardial infarction, sudden death, or ischemic heart disease(2,4,9-12). Prompt diagnosis using intra-venous immunoglobulin (IVIG) can reduce the incidence of coronary artery abnormalities from 20-25% to 5%(13,14). Reported risk factors for coronary artery lesions include delayed diagno-sis(15,16) and an age of onset outside the typical age distribution(17,18). Some studies have shown that risk factors for delayed diagnosis include an age of < 6 mo and incomplete KD(16). In addition, more patients are being diagnosed who do not meet the classic diagnostic criteria(19). It has been reported that in incomplete KD and younger children, the clinical features are fewer and more subtle and consequently, diagnosis may be more difficult and delayed(16).

Although conventional diagnostic criteria are useful in preventing overdiagnosis, some studies suggest that these should be revised to include guidelines that recognize incomplete forms of KD(2,20), and a revision of new diagnostic guidelines has been attempted(21,22). General pediatricians may hesitate to make an early diagnosis and treat those outside the typical age range (£6 mo and ³5 y of age) and those who do not fully meet the classic criteria. This may delay diagnosis and prompt treatment, and worsen outcome, as discussed above(23). In this study the clinical features, laboratory findings and outcome were compared in patients with KD within and outside the typical age range.

Methods

A total of 198 patients with KD were treated at Severance Children’s Hospital of Yonsei University College of Medicine, Seoul, Korea, between 2006 and 2007. Thirteen cases of recurrent KD were excluded. To investigate age-related differences in clinical characteristics, a retrospective analysis of 185 KD children with a discharge diagnosis of KD was performed after seeking approval from the Institute’s Ethics Committee. Diagnosis of KD was made as per AHA Guidelines(2). Subjects were also evaluated to determine whether they satisfied the classic diagnostic criteria. Incomplete KD was defined as meeting less than 4 clinical criteria, irrespective of echocardiography findings(2,24,25). Overall, there were 63 (34%) cases with classic KD and 122 cases with incomplete KD (66%). Subjects were categorized by age in Group A (22 cases, £5 mo of age), Group B (131 cases, 6 mo-4 y of age) and group C (32 cases, ³5 y of age).

All children were treated with IVIG at a dose of 2 g/kg and a high dose of aspirin (100 mg/kg) during the febrile period, in keeping with current consensus guidelines(3,4). Additional IVIG (2 g/kg) was given when fever persisted for more than 48 h, even after the initial IVIG infusion.

Echocardiography was performed within 2 wk of the onset of illness, during the 4th wk, and subsequently repeated depending on the initial findings. Coronary artery lesion (CAL) was defined as an internal lumen diameter >3 mm in children <5 y of age or >4 mm in children ³5 y of age, if the internal diameter of a segment measured ³1.5 times that of an adjacent segment, or if the lumen was clearly irregular (the Japanese Ministry of Health criteria)(26). When a coronary artery was larger than normal (dilated) and without a segmental aneurysm, the vessel was considered ecstatic(2). All patients underwent laboratory investigations for leukocyte (WBC) count, hemoglobin, thrombocyte, C-reactive protein, erythrocyte sedimentation rate, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, creatine kinase (CK), CK-MB, N-terminal fragment of B-type natriuretic peptide (NT-proBNP), and urine WBC, which were performed at admission and 1 day after the initial IVIG infusion, in keeping with normal clinical practice at our hospital.

Statistical analysis was performed using SPSS 13.0 for Windows. The three age groups were compared for clinical characteristics including presence of coronary artery lesions, hematological and bio-chemical parameters, and for presence of classical or incomplete KD. The means of the continuous variables in the 3 age groups were compared using 1-way ANOVA. If there were significant differences among the 3 groups, identification of the 2 groups that showed significant differences were made by post hoc tests (Scheffe, LSD and Tukey’s). Chi-square test was used for comparing categorical variables. A probability of £0.05 was considered statistically significant.

Results

The average age of 185 children with KD was 2.8 year, with a range of 1 month to 10 years. The clinical features are summarized in Table I. The most common clinical feature was fever, followed by red lips and red eyes.Sixty-three of 185 (34%) children fulfilled the diagnostic criteria for Classical KD and 122 (66%) were diagnosed with Incomplete KD. Incomplete KD was found in 15 (68%) children in Group A, 88 (67%) in Group B, and 19 (59%) in Group C (P>0.05).

TABLE I



Clinical Characteristics of Kawasaki Disease According to Age at Diagnosis
  Group A
≤5 mo (n = 22)
Group B
6 mo-4 y (n = 131)
Group C
≥5 y (n = 32)
P-value
 
Mean age (mo) 3.5 27 78 0
Male/female 11/11 73/58 13/19 NS
Fever duration(d, mean ± SD) 4.73 ± 3.14 4.91 ± 4.13 6.69 ± 5.82 NS
Clinical signs (%)
  Skin rash 14 (64) 87 (66) 17 (53) NS
  Cervical nodes 7 (32) 47 (36) 17 (53) NS
  Red eyes 15 (68) 95 (73) 23 (72) NS
  Red lips 19 (86) 103 (79) 28 (88) NS
  Changes in extremities 8 (36) 58 (44) 14 (44) NS
  BCG erythema 16 (73) 44 (34) 1 (3) 0.001
  Anal desquamation 1 (5) 15 (12) 2 (6) NS
  GB hydrops 4 (20) 15 (13) 2 (8) NS
NS: not significant, GB: gallbladder.

Laboratory findings between the three age groups are compared in Table II. Marked leukocytosis and thrombocytosis on admission were noted more in children <6 months of age. The incidence of sterile pyuria was 14% (26 cases overall: 2 in group A, 20 in group B, and 3 in group C) with statistical insignificance between groups (P=0.16). The incidence of coronary artery lesions was comparable both at admission and 6 months later, in all age groups (Table III). The overall recurrence rate was 0.3% with no significant differences between groups (P=0.5:1 case in group A, 5 in group B, and none in group C).

TABLE II



Laboratory Findings of Kawasaki Disease Before IVIG Treatment
  Group A (n = 22) Group B (n = 131) Group C (n = 32) P value
WBC (x103/mm3) 16.1 ± 6.1 12.8 ± 5.5 10.4 ± 3.9 0.001
Hemoglobin (g/dL) 15.5 ± 2.6 12.5 ± 0.9 11.9 ± 0.9 NS
Platelet count (x103/mm3) 511 ± 304 385 ± 137 331 ± 136 0.01
ESR (mm/h) 47 ± 34.7 54 ± 38.4 50 ± 35.0 NS
CRP (mg/dL) 5.1 ± 4.7 5.7 ± 6.4 6.1 ± 6.2 NS
AST (IU/L) 56 ± 64.5 104 ± 209.0 48 ± 56.8 0.045
ALT 40 ± 42.2 99 ± 164.0 35 ± 75.3 0.09
LDH (IU/L) 517 ± 88.2 615 ± 202.2 501 ± 180.1 0.03
CK (IU/L) 77 ± 65.2 129 ± 172.3 180 ± 326.8 NS
MB (ng/mL) 3 ± 1.3 4 ± 2.1 4 ± 4.1 NS
MB/CK 6 ± 3.3 5 ± 3.2 5 ± 7.5 NS
NT-proBNP (pg/mL) 1203 ± 959.6 1257 ± 3795.3 632 ± 1864.3 NS
Urine WBC 0 0.02 ± 0.14 0.07 ± 0.26 NS
NS: not significant; WBC: White blood cells; ESR: Erythrocyte sedimentation rate; 

CRP: C-reactive protein; AST: Aspartate aminotransferase; 

ALT: Alanine aminotransferase; LDH: Lactate dehydrogenase; CK: Creatine Kinase; 

MB: Creatine kinase - MB components; NT: ProBNB: N-terminal fragment of B-type natriuretic peptide.
TABLE III



Coronary Artery Lesions in Kawasaki Disease
  Group A (n = 22) Group B (n = 131) Group C  (n = 32) Total P value
Initial CALs (%) 3 (1.6%) 13 (7.0%) 1 (0.5%) 17 (9.2%) 0.74
F/U CALs (%) 3 (1.6%) 6 (3.2%) 1 (0.5%) 10 (5.4%) 0.15
CALs: coronary artery lesions, F/U: follow up.

Discussion

There have been many reports of the different features of KD outside the typical age range of the disease. In some studies, patients <6 mo of age were at increased risk for CALs, giant aneurysms, incomplete KD, and atypical features(17,27). Other studies have shown that older children and adolescents with KD were predominantly male, had delayed diagnosis of KD, higher incidence of cervical lymphadenopathy, and presence of additional symptoms such as abdominal and joint pain as well as higher rates of CAL(18,23,28,29).

We did not observe any variation in the clinical presentation of children at various ages, except that the erythema at BCG site was more pronounced in children <6 months. In laboratory parameters, leuco-cytosis and thrombocytosis were more prominent in younger infants. However, the incidence of incomplete Kawasaki disease and coronary artery lesions remained comparable at all ages. The major strength of this study is a large sample size analyzed in different age groups. However, most of the children (66%) had incomplete Kawasaki disease.

While children outside the typical age range (<6 mo and >5 y) are reported to be at higher risk for CALs in some reports (23,27,29), CALs occurred equivalently in all age groups in this study, suggesting that the risk of CAL may not be increased in those who receive early IVIG therapy. Initially, the incidence of CAL was 9% overall in this study, which was similar to other reports, but showed a decreased rate of incidence of 5% on 6-month follow-up echocardiography, as compared to other studies. This may be due to earlier echocardiography performed within the first week of disease onset, unlike in other studies. There were no other cardiac manifestations presenting as heart failure, which may explain the elevated NT-proBNP. However, we found that 7 (4%) cases had pericardial effusion on echocardiography, though it is not a CAL category.

With no specific diagnostic test for KD, phy-sicians are likely to diagnose it on the basis of clinical findings. Rigorous application of the classical clinical diagnostic criteria is inappropriate and may result in missed diagnoses(2). Since some clinical and laboratory findings are characteristic, they can help prevent misdiagnosis(20). BCG site change and NT-proBNP may be highly suggestive markers for acute KD to differentiate from other acute febrile illnesses and also be useful as additional diagnostic tools(30). Recently published less stringent diagnostic algorithms may prove particularly useful, especially in younger age groups(2,22). Further research is needed to continue the revision of diagnostic criteria of the Kawasaki disease.

Contributors: All authors contributed to the study design, acquisition of data and its analysis, and writing the report.

Funding: None.

Competing interests: None stated.

What is Already Known?

• Kawasaki disease is associated with coronary artery lesions; this might be related to the age at which the disease occurs.

What This Study Adds?

• In 185 children diagnosed with Kawasaki disease (Classical: 63; imcomplete: 122), there were no major differences in clinical presentation with respect to age, including the incidence of coronary artery lesions.

References

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967; 16: 178-222.

2. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-2771.

3. Satou GM, Giamelli J, Gewitz MH. Kawasaki disease: diagnosis, management, and long-term implications. Cardiol Rev 2007; 15: 163-169.

4. Tsuda E, Kawamata K, Neki R, Echigo S, Chiba Y. Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan. Cardiol Young 2006; 16: 173-178.

5. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991; 119: 279-282.

6. Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994; 13: 704-708.

7. Barron KS, Shulman ST, Rowley A, Taubert K, Myones BL, Meissner HC, et al. Report of the National Institutes of Health Workshop on Kawasaki disease. J Rheumatol 1999; 26: 170-190.

8. Park YW, Han JW, Park IS, Kim CH, Cha SH, Ma JS, et al. Kawasaki disease in Korea, 2003-2005. Pediatr Infect Dis J 2007; 26: 821-823.

9. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364: 533-544.

10. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87: 1776-1780.

11. Kato H, Sugimura T, Akagi T, Sato N, HashinoK, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996; 94: 1379-1385.

12. Fulton DR, Newburger JW. Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep 2000; 2: 324-329.

13. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341-347.

14. McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 2007; 116: 174-179.

15. Wilder MS, Palinkas LA, Kao AS, Bastian JF, Turner CL, Burns JC. Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome. Pediatr Infect Dis J 2007; 26: 256-260.

16. Minich LL, Sleeper LA, Atz AM, McCrindle BW, Lu M, Colan SD, et al. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics 2007; 120: 1434-1440.

17. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995; 126: 524-529.

18. Stockheim JA, Innocentini N, ST Shulman. Kawasaki disease in older children and adolescents. J Pediatr 2000; 137: 250-252.

19. Witt MT, Minich L, Bohnsack J, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics 1999;104:e10.

20. Kim DS. Kawasaki disease. Yonsei Med J 2006; 47: 759-772.

21. Muta H, Ishii M, Iemura M, Suda K, Nakamura Y, Matsuishi T. Effect of revision of Japanese diagnostic criterion for fever in Kawasaki disease on treatment and cardiovascular outcome. Circ J 2007; 71: 1791-1793.

22. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47: 232-234.

23. Pannaraj PS, Turner CL, Bastian JF, Burns JC. Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr Infect Dis J 2004; 23: 789-791.

24. Rowley AH. Incomplete (atypical) Kawasaki disease. Pediatr Infect Dis J 2002; 21: 563-565.

25. Rowley AH, Gonzalez F, Gidding SS, Duffy CE, Shulman ST. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987; 110: 409-413.

26. Yanagawa H, Nakamura Y. International comparison of the epidemiology of Kawasaki disease. Nippon Rinsho 2008; 66: 237-245.

27. Genizi J, Miron D, Spiegel R, Fink D, Horowitz Y. Kawasaki disease in very young infants: high prevalence of atypical presentation and arteritis. Clin Pediatr 2003; 42: 263-267.

28. Lee KY, Hong JH, Han JW, Lee JS, Lee BC, Burgner D. Features of Kawasaki disease at the extremes of age. J Paediatr Child Health 2006; 42: 423-427.

29. Fan PC, Chiu CH, Yen MH, Huang YC, Li CC, Lin TY. School-aged children with Kawasaki disease: high incidence of cervical lymphadenopathy and coronary artery involvement. J Paediatr Child Health 2003; 39: 55-57.

30. Lee H, Kim H, Kim HS, Sohn S. NT-pro BNP: A new diagnostic screening tool for Kawasaki disease. Kor J Pediatr 2006; 49: 539-544.
 

 

Copyright© 1999 by the Indian Pediatrics (Disclaimer)